
Bupa Cromwell Hospital and GenesisCare collaborate to bring world-class radiotherapy services to patients in London
- Cancer patients will have rapid access to pioneering technology, with a new MR Linac capable of targeting tumours more precisely from spring 2020
- The service will be the first of its kind in London outside of a research study
- GenesisCare’s investment over the next year will also bring a wide range of high-end technology and personalised patient treatments to create a centre of excellence
About GenesisCare Global: GenesisCare delivers treatment to people with cancer and heart disease, the two largest disease burdens globally. We’re committed to leading the change in how care is designed and given and are currently leading or participating in more than 100 clinical trials. The organisation employs more than 2,500 highly trained healthcare professionals and support staff across the UK, Europe, Australia and now China, including some of the world’s most experienced specialists. Every year GenesisCare clinical teams see more than 160,000 people at more than 130 locations. For cancer treatment, that includes 12 centres in the UK, 21 in Spain and 30 in Australia, with more than 20 new centres under development. We also offer cardiology and sleep services at more than 80 locations across Australia. Our purpose is to design care experiences that get the best possible life outcomes. We believe that care should be focused on the individual, not the condition, and are proud of our patient satisfaction ratings, which place us in the top 1 per cent of outpatient healthcare organisations in the world. For more information visit www.genesiscare.com. About Bupa Cromwell Hospital: Bupa Cromwell Hospital was established in 1981 and acquired by Bupa, leading international healthcare group, in March 2008. It is a leading London hospital renowned for being the first to invest in some of the UK’s leading-edge equipment and cancer services. Based in West London, the hospital has over 500 accredited consultants, mainly drawn from London’s teaching hospitals, covering over 70 specialities. It is recognised as a centre of excellence for oncology, cardiology, paediatrics, orthopaedics, lung, complex surgery and medicine. Bupa Cromwell Hospital's diagnostics service offers the very latest technology. There are two ambient MRI scanners and the angiography suite offers the most up-to-date imaging available in London. Consultants use the latest surgical techniques and have access to advanced non-invasive technologies, such as Gamma Knife surgery and robot-assisted joint replacement surgery. Outpatient services include private GPs, health screening and family medicine services. The hospital has 120 beds and boasts a large and loyal UK and international clientele, admitting self-pay, embassy sponsored patients and those funded by medical insurance. Bupa Cromwell Hospital constantly strives to provide a first-class service to its patients through the use of state-of-the-art technology, innovative diagnostics and a continuous investment programme. For more information visit www.bupacromwellhospital.com. For further information GenesisCare UK enquiries: Cello Health Communications Email: CommsCA-GenesisCare@ch-corporateAffairs.co.uk Tel: 02034346977 GenesisCare corporate enquiries: Email: Nkassulke@Cannings.net.au Tel: +61 407 904 874 Bupa Cromwell Hospital enquiries: Duncan West, Head of Corporate Communications, Bupa UK Email: bupapressoffice@bupa.com Tel: 020 7833 7040
Editor Details
-
Company:
- Cello Health Communications
-
Name:
- emily coppen
- Email:
- Website: